KIA-Korekt: Staged Unimodal-to-Multimodal AI Evaluation for Perioperative Risk Prediction in Colorectal Cancer
KIA-Korekt
Staged Unimodal-to-Multimodal AI Analysis of Histopathology, CT/MRI, and Multiplex Tissue Imaging for Perioperative Risk Prediction in Colorectal Cancer (KIA-Korekt)
1 other identifier
observational
910
1 country
1
Brief Summary
Perioperative complications following surgery for colorectal cancer (CRC) represent a major cause of postoperative morbidity and mortality. Existing risk stratification tools lack the precision to capture the complex biological and morphological factors that determine individual patient vulnerability. Artificial intelligence (AI)-based analysis of medical imaging data offers a promising approach to improve preoperative risk prediction. The KIA-Korekt study investigates whether perioperative complications in CRC patients can be predicted using multimodal AI-based image analysis. Three complementary imaging modalities are integrated: digital histopathology (haematoxylin-eosin whole-slide images, H\&E-WSIs), preoperative CT and MRI radiomics, and multiplex tissue imaging (mTI) including multiplex immunohistochemistry (mIHC) and imaging mass cytometry (IMC). The study includes a retrospective cohort of approximately 750 CRC patients treated between 2011 and 2021, and a prospective validation cohort of approximately 210 patients recruited from 2026 to 2028. Deep learning and radiomic feature extraction pipelines are applied to all modalities individually and in multimodal combination. Predicted outcomes include anastomotic leakage, wound infection, sepsis, ICU admission, and in-hospital mortality within 30 days of surgery. The study is conducted at the University Hospital Brandenburg, Brandenburg Medical School Theodor Fontane, in collaboration with the Department of Computational Pathology, TU Dresden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
April 17, 2026
April 1, 2026
17 years
April 8, 2026
April 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prediction accuracy of perioperative complications
Occurrence of postoperative complications including anastomotic leakage, sepsis, ICU admission, and in-hospital mortality. Outcomes are defined based on clinical documentation and assessed as binary variables (yes/no).
30 days postoperative
Study Arms (2)
Group 1: Retrospective Training Cohort
Patients with colorectal cancer treated between 2011-2021 with available imaging and histopathology data.
Prospective Cohort
Patients with colorectal cancer enrolled prospectively between 2026-2028.
Eligibility Criteria
Adult patients (≥18 years) with histologically confirmed colorectal cancer undergoing surgical treatment at a tertiary care center. The study includes both retrospectively collected patients (2011-2021) and prospectively enrolled patients (2026-2028) with available imaging and histopathological data.
You may qualify if:
- Adult patients (≥18 years)
- Histologically confirmed colorectal adenocarcinoma
- Undergoing surgical resection (curative or palliative intent)
- Availability of H\&E-stained whole-slide images (WSIs) from the primary tumour
You may not qualify if:
- Patients not undergoing surgical treatment
- Missing H\&E-stained tissue slides of the primary tumour
- Histopathological material of insufficient quality for analysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rene Mantkelead
- Technische Universität Dresdencollaborator
Study Sites (1)
University Hospital Brandenburg an der Havel, Brandenburg an der Havel, Germany (Single-center)
Brandenburg an der Havel, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Univ.-Prof. Dr. med.
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 17, 2026
Study Start
January 1, 2011
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
June 30, 2028
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share